Foot And Mouth Disease Vaccine Market (2026 - 2033)

Foot And Mouth Disease Vaccine Market Summary

The global foot and mouth disease vaccine market was valued at USD 2.7 billion in 2025 and is projected to grow from USD 2.9 billion in 2026 to USD 5.1 billion in 2033, at a CAGR of approximately 8.8% from 2026 to 2033. The Asia Pacific dominated the market, accounting for a revenue share of 45.0% in 2025. The increasing livestock population and demand for animal products are significant factors contributing to market growth. In addition, with rapid globalization and climate change, livestock diseases have been increasing over the past few decades. To ensure safe healthcare practices for companion animals and livestock, the government has undertaken various initiatives and programs. Thereby, contributing to the growth of the veterinary vaccine market, of which foot and mouth disease (FMD) vaccines capture a significant share.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

The growing human population has driven the demand for animal products such as milk, chicken, eggs, and meat. Vaccines help minimize animal loss and ensure their safety, which is likely to drive market growth over the forecast period. The increasing production and consumption of milk and milk products in countries such as India are further expected to contribute to market growth.

In developing countries, livestock is a contributor to GDP; hence, there is increasing demand for efficient animal healthcare practices, which is expected to drive growth in this market over the forecast period. For instance, in July 2024, according to information published by the Ministry of Finance (India), 4.6% of total GVA in 2022-23 was contributed by the livestock sector, thereby boosting the per capita availability of milk, eggs, and meat. The livestock population has increased rapidly owing to the adoption of advanced medication and vaccination programs to maintain livestock health.

Various government initiatives and programs have boosted growth in this market. According to the Food and Agriculture Organization of the U.S. and the World Organization for Animal Health, SEACFMD 2021-2025 was launched to increase productivity and economic output in the livestock sector by managing and eradicating FMD, thereby enhancing food security and supporting rural smallholder farmers. Investments made by government institutions have supported the production of FMD vaccines and boosted the market growth.

Analyst Perspective

The global foot-and-mouth disease (FMD) vaccine market is expected to grow steadily, driven by increasing government-led livestock vaccination programs, rising concerns over food security, and the economic impact of FMD outbreaks on the livestock industry. Manufacturers are focusing on developing multivalent, high-efficacy, and thermostable vaccines to improve protection against multiple FMD virus serotypes and enhance vaccine accessibility in resource-limited regions. Although challenges such as antigenic variation, cold-chain requirements, and regulatory complexities persist, continued investments in vaccine innovation, regional manufacturing, and disease eradication initiatives are expected to support long-term market growth.

Animal Insights

Cattle dominated the market with a market share of over 50.0% in 202 and is expected to grow at the fastest CAGR over the forecast period. Cattle are highly prone to contracting FMD and experience severe symptoms such as blisters inside the mouth and on the feet, fever, and reduced milk production. Even subclinical infections can cause milk yields to drop by 30-40%. Outbreaks in cattle herds have major economic consequences for farmers due to loss of productivity, the high costs of control measures, and culling infected animals. Hence, there is an increased demand for improved healthcare practices such as vaccination. For instance, the National Animal Disease Control Program in India works to control FMD by 2025 and eradicate it by 2030 with vaccination. All these factors have contributed to the growth of this segment in the foot and mouth disease vaccine market over the forecast period.

The swine segment is expected to grow at a significant CAGR over the forecast period. It is attributed to the rising demand for pork, as it is a good source of protein and a source of income in many developing countries worldwide. This growth necessitates enhanced vaccination efforts to prevent FMD outbreaks, which can severely impact production and drive market growth.

Vaccine Insights

The inactivated (killed) vaccine segment dominated the market, accounting for over 50.0% of the market share in 2025. Its high efficacy and safety, longer duration of immunity, regulatory approval and acceptance, and the need for preventive health measures contribute to the dominance of inactivated vaccines in the FMD vaccine market.

The modified/attenuated live segment is expected to grow at a significant CAGR during the forecast period. This can be attributed to its strong immune response and cost-effectiveness. In addition, many governments are implementing vaccination programs to control FMD outbreaks, and modified live vaccines are often a preferred choice due to their effectiveness. Increased funding and initiatives to improve livestock health are expected further to drive growth in this segment over the forecast period.

Distribution Channel Insights

The government institutions segment accounted for a significant market share in 2025, attributed to their strong regulatory framework, public health and economic stability, and funding/support for vaccination programs. Many governments provide funding and resources for FMD vaccination initiatives, especially in regions where the disease is endemic. This support includes the development and distribution of vaccines, which enhances access and increases vaccination rates among livestock populations. Thereby boosting the market growth positively. For instance, in February 2025, the Government of India reaffirmed its commitment to the National Animal Disease Control Program (NADCP), which provides full central assistance to States and Union Territories for Foot-and-Mouth Disease (FMD) vaccination. The government also maintains centralized procurement and supply of FMD vaccines, offers financial support for vaccination accessories and cold-chain infrastructure, and conducts stakeholder awareness programs.

The veterinary hospitals & clinics segment is expected to grow at a significant CAGR during the forecast period. It can be attributed to the increasing demand for animal health services, focus on preventive care, and growing awareness amongst livestock owners. In addition, many governments and animal health organizations are implementing programs that promote vaccination through veterinary clinics. This support includes funding for vaccination campaigns and training for veterinary professionals, thereby enhancing clinics' capacity to provide FMD vaccines. Thereby fueling the market growth over the forecast period.

Regional Insights

The Asia Pacific foot and mouth disease vaccine dominated the market, accounting for a revenue share of 45.0% in 2025, owing to the growing livestock population and high prevalence of FMD in this region. The developing healthcare sector, government funding, and investment have contributed to market growth over the forecast period. In addition, the rising awareness among livestock owners plays a significant role. The governments of the Asia-Pacific countries have been involved in raising awareness of the importance of treating FMD and eradicating it.

To learn more about this report, Download Free Sample Report

India foot and mouth disease vaccine market is expected to grow significantly over the forecast period. Government initiatives play a significant role in boosting market growth. In addition, the government’s initiatives and funding in India during 2022-2023 include Accredited Agent for Health and Extension of Livestock Production (A-HELP), Mobile Veterinary Units (MVUs) to increase accessibility of veterinary services at farmer’s doorsteps, and Animal Health Support System for One Health for five years in five states of India - Assam, Karnataka, Madhya Pradesh, Maharashtra, and Odisha.

MEA Foot And Mouth Disease Vaccine Market Trends

MEA foot and mouth disease vaccine market is anticipated to witness significant growth over the forecast period. The growing livestock population in the MEA region increases the risk of FMD outbreaks and the need for vaccination. As livestock farming becomes more intensive, the demand for effective vaccines to protect these animals rises. In addition, as countries in the MEA region seek to enhance their livestock exports, maintaining FMD-free status becomes crucial. Vaccination is a key strategy to achieve this status, and governments have implemented various promotional measures to drive demand for FMD vaccines further. For instance, in May 2024, the Ugandan and Egyptian governments partnered to launch local production of vaccines for Foot and Mouth Disease (FMD). In addition, in January 2026, Biogénesis Bagó announced it would supply high-potency foot-and-mouth disease (FMD) vaccines to South Africa, supporting the country's efforts to contain ongoing outbreaks. Initially delivering one million vaccine doses with additional shipments planned, strengthening and expanding vaccination programs, thereby supporting the demand for FMD vaccines across the region.

Europe Foot And Mouth Disease Vaccine Market Trends

Europe foot and mouth disease vaccine market is anticipated to witness substantial growth over the forecast period due to the reactive vaccination strategy. Various government strategies have helped control FMD in European Countries. For instance, in May 2025, the Food and Agriculture Organization (FAO) urged European countries to strengthen surveillance, biosecurity, preparedness, and vaccination strategies following the region's worst outbreaks of foot-and-mouth disease (FMD). The initiative emphasized coordinated disease control measures to protect livestock health, facilitate safe trade, and improve resilience against future outbreaks, a focus expected to drive demand for FMD vaccines across Europe.

Latin America Foot And Mouth Disease Vaccine Market Trends

The Latin America foot-and-mouth disease vaccine market was identified as a lucrative market in 2025. Latin America has a substantial livestock population, particularly cattle, which are highly susceptible to FMD. This large population creates a continuous demand for effective vaccination to prevent outbreaks and maintain herd health. Thereby boosting market growth in this region. Government programs have contributed to a significant change in animal health practice in Brazil. In addition, according to a report by the Ministry of Agriculture and Livestock, the Strategic Plan for the National Foot and Mouth Disease Surveillance Program (PE-PNEFA) ensures that the country remains free from foot-and-mouth disease.

Key Foot And Mouth Disease Vaccine Company Insights

Some of the companies in the foot and mouth disease vaccine market include Merck & Co., Inc., Biogenesis Bago, Zoetis Services LLC, Boehringer Ingelheim International GmbH, and others. These companies are growing their market revenue by launching new products, entering into collaborations, and adopting other strategies.

Key Foot And Mouth Disease Vaccine Companies

The following key companies have been profiled for this study on the foot and mouth disease vaccine market:

• Biogénesis Bagó

• Zoetis Services LLC

• Boehringer Ingelheim International GmbH

• Bayer AG

• HESTER BIOSCIENCES LIMITED

• Botswana Vaccine Institute

• China Animal Husbandry Industry Co. Ltd.

• MEVAC

• Ourofino

Recent Developments

• In December 2025, Biogénesis Bagó, with the Paraná Technological Institute (Tecpar), established Brazil's first Foot-and-Mouth Disease (FMD) antigen and vaccine bank under a 10-year agreement. The initiative will create a strategic reserve of 10 million antigen doses and enable the rapid production and deployment of emergency FMD vaccines within 72 hours of an outbreak.

• In July 2024, Biogénesis Bagó opened a vaccine production plant in Brazil with an annual production capacity of live attenuated virus vaccines for FMD of over 10 million doses.

Global Foot And Mouth Disease Vaccine Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the global foot and mouth disease vaccine market report based on animal, vaccine, distribution channel, and region:

• Animal Outlook (Revenue, USD Billion, 2021 - 2033)

  • Cattle

  • Sheep and Goat

  • Swine

  • Others

• Vaccine Outlook (Revenue, USD Billion, 2021 - 2033)

  • Modified/ Attenuated Live

  • Inactivated (Killed)

  • Other Vaccines

• Distribution Channel Outlook (Revenue, USD Billion, 2021 - 2033)

  • Veterinary Hospitals & Clinics

  • Government Institutions

  • Others

• Regional Outlook (Revenue, USD Billion, 2021 - 2033)

  • Europe

    • Russia

    • France

  • Asia Pacific

    • Japan

    • China

    • India

    • South Korea

    • Indonesia

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • MEA

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait

    • Egypt

    • Turkey